Furthermore, GLP-1 RAs are not recommended for patients with severe gastrointestinal diseases (e.g., gastroparesis and inflammatory bowel disease); with a personal or family history of multiple endocrine neoplasia 2A, multiple endocrine neoplasia 2B, or medullary thyroid cancer (89). The gene discussed is GLP1R; the disease is inflammatory bowel disease.